Order Article Reprints

Janjetovic Z, Qayyum S, Reddy SB, Podgorska E, Scott SG, Szpotan J, Mobley AA, Li W, Boda VK, Ravichandran S, et al. Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells. 2024; 13(3):239. https://doi.org/10.3390/cells13030239

Janjetovic, Zorica, Shariq Qayyum, Sivani B. Reddy, Ewa Podgorska, S. Gates Scott, Justyna Szpotan, Alisa A. Mobley, Wei Li, Vijay K. Boda, Senthilkumar Ravichandran, and et al. 2024. "Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts" Cells 13, no. 3: 239. https://doi.org/10.3390/cells13030239

Janjetovic, Z., Qayyum, S., Reddy, S. B., Podgorska, E., Scott, S. G., Szpotan, J., Mobley, A. A., Li, W., Boda, V. K., Ravichandran, S., Tuckey, R. C., Jetten, A. M., & Slominski, A. T. (2024). Novel Vitamin D3 Hydroxymetabolites Require Involvement of the Vitamin D Receptor or Retinoic Acid-Related Orphan Receptors for Their Antifibrogenic Activities in Human Fibroblasts. Cells, 13(3), 239. https://doi.org/10.3390/cells13030239